Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • Medication Access During Natural Disasters
  • Suicide Prevention
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Requirements
  • Medication Access During Natural Disasters
  • Suicide Prevention
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Oct 18 2022

Full Issue

White House Worries New Variants Could Beat Evusheld Preventive Drug

Stat reports on Biden administration health officials' concerns that AstraZeneca’s Evusheld, a monoclonal antibody drug that's become essential for immunocompromised Americans, could be bypassed by emerging variants. Meanwhile, the covid czar urges seniors to get new boosters.

Stat: Biden Officials Scramble As Covid Variants Test Evusheld's Effectiveness

Biden health officials are bracing for the prospect that the country’s sole preventive Covid-19 treatment for immunocompromised people could be ineffective this winter. (Owermohle, 10/18)

CNBC: White House Covid Czar Calls On Seniors To Get Omicron Booster Now

A top White House health official on Monday issued a stark warning to older people about the health risk they face this fall and winter from Covid-19. (Kimball, 10/17)

The Hill: US Warned To Get Ready As Europe Deals With New COVID-19 Rise 

The most recent data from the European Centre for Disease Prevention and Control shows that cases began going up around the beginning of September in Europe.  The seven-day average is roughly 230,000 cases per day, reflecting rates that were seen in late July when Europe was still dealing with the omicron BA.4/BA.5 subvariant wave. (Choi, 10/17)

CNBC: Dr. Fauci: Covid Omicron Subvariants BQ.1, BQ.1.1 Are 'Troublesome'

As winter inches closer, Dr. Fauci is sounding the alarm about a pair of “pretty troublesome” Covid variants. The two descendants of omicron’s BA.5 subvariant, called BQ.1 and BQ.1.1, both have dangerous “qualities or characteristics that could evade some of the interventions we have,” Fauci told CBS News on Friday. (Constantino, 10/17)

The Atlantic: How To Make Sense Of This Fall's Messy COVID Data

Official case numbers now represent “the tip of the iceberg” of actual infections, Denis Nash, an epidemiologist at the City University of New York, told me. Although case rates may seem low now, true infections may be up to 20 times higher. And even those case numbers are no longer available on a daily basis in many places, as the CDC and most state agencies have switched to updating their data once a week instead of every day. (Ladyzhets, 10/17)

AP: Governor To End California Coronavirus Emergency In February 

California’s coronavirus emergency will officially end in February, Gov. Gavin Newsom announced Monday, nearly three years after the state’s first confirmed death from the disease prompted a raft of restrictions that upended public life. (Beam, 10/17)

And scientists are under fire for their work on a lab-made version of covid —

Stat: Boston University Researchers’ Testing Of Lab-Made Version Of Covid Virus Draws Government Scrutiny

Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus is garnering heated headlines alleging the scientists involved could have unleashed a new pathogen. (Branswell, 10/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF